Literature DB >> 1615105

Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment.

S Arndt1, G Tyrrell, M Flaum, N C Andreasen.   

Abstract

Co-morbid substance use and abuse is common in schizophrenic patients, and the role of substance abuse in initiating and maintaining psychosis has important definitional and aetiological implications. We investigated the issue in a cohort of 131 schizophrenic patients. We found non-users (N = 67) were similar to pathological users (N = 64) in current symptomatology and clinical history. The pathological users did, however, have better pre-morbid adjustment levels. Only alcohol use and to some extent cannabis use contributed to this effect; use of stimulants or hallucinogens did not. These results indicate the importance of evaluating the various types of substance used when attempting to explore the significance of co-morbidity. The results also suggest that co-morbidity of substance abuse and schizophrenia may be explained by a common factor antecedent to both: better pre-morbid adjustment. A two-stage model is proposed to explain these findings: increased sociability increases exposure to opportunities of substance use in a subset of patients; subsequent onset of psychotic illness accelerates the use to a pathological level as the individual attempts to cope with the stress of the developing mental illness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1615105     DOI: 10.1017/s0033291700030324

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  22 in total

1.  Longitudinal effects of integrated treatment on alcohol use for persons with serious mental illness and substance use disorders.

Authors:  S E Herman; K A Frank; C T Mowbray; K M Ribisl; W S Davidson; B BootsMiller; L Jordan; A L Greenfield; D Loveland; D A Luke
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

2.  Use of potentially abusive psychotropic substances in psychiatric inpatients.

Authors:  J Modestin; C Nussbaumer; K Angst; P Scheidegger; D Hell
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

3.  Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.

Authors:  Serge Sevy; Delbert G Robinson; Barbara Napolitano; Raman C Patel; Handan Gunduz-Bruce; Rachel Miller; Joanne McCormack; Beth S Lorell; John Kane
Journal:  Schizophr Res       Date:  2010-05-14       Impact factor: 4.939

4.  Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Authors:  Daniel J Foti; Roman Kotov; Lin T Guey; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2010-05-17       Impact factor: 18.112

5.  A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties.

Authors:  Yoshihiro Kinoshita; David Kingdon; Kuni Kinoshita; Sheeba Sarafudheen; Deepa Umadi; David Dayson; Lars Hansen; Shanaya Rathod; Richard B Ibbotson; Douglas Turkington; Toshi A Furukawa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-08       Impact factor: 4.328

6.  Substance abuse and cognitive functioning in schizophrenia.

Authors:  J Addington; D Addington
Journal:  J Psychiatry Neurosci       Date:  1997-03       Impact factor: 6.186

7.  Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.

Authors:  Rachel A Rabin; Mera S Barr; Michelle S Goodman; Yarissa Herman; Konstantine K Zakzanis; Stephen J Kish; Michael Kiang; Gary Remington; Tony P George
Journal:  Neuropsychopharmacology       Date:  2017-04-26       Impact factor: 7.853

8.  Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders.

Authors:  Serge Sevy; Katherine E Burdick; Hema Visweswaraiah; Sherif Abdelmessih; Meredith Lukin; Eldad Yechiam; Antoine Bechara
Journal:  Schizophr Res       Date:  2007-03-26       Impact factor: 4.939

Review 9.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

10.  A retrospective analysis of cannabis use in a cohort of mentally ill patients in Sri Lanka and its implications on policy development.

Authors:  Chaturaka Rodrigo; Srina Welgama; Alwis Gunawardana; Chinthaka Maithripala; Gamini Jayananda; Senaka Rajapakse
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.